Skip to content
  • Twitter
  • Facebook
  • LinkedIn
  • Instagram
  • YouTube
  • Intranet
  • Español
  • English
INCLIVA – Instituto de Investigación Sanitaria Logo
  • ABOUT US
    • 25 años de INCLIVA
    • About us
    • Where we are
    • Organizational chart
      • Governing Bodies
      • Advisory Bodies
    • Structure
    • Scientific Report
    • Contractor Profile
    • Transparency portal
    • Quality
    • Data protection
    • Responsible Research and Innovation (RRI)
  • WHAT WE DO
    • Areas
    • Research Portal
    • Cross-cutting Programmes
    • Emerging Researchers
  • SERVICES
    • Platforms
    • Researcher Services
    • Communication Unit
    • Quality and Data Protection Unit
    • Innovation Support Unit
    • Computing Unit
  • CLINICAL TRIALS
  • INTERNATIONAL
  • CEIm
    • Composition
    • Evaluation requirements
    • Activity Reports
  • TRAINING
  • WORK WITH US
    • Job Offers
    • Human Resources Strategy
    • Equal Opportunities
  • NEWS
  • COLLABORATE
    • DONATE
    • Your solidarity campaign
    • Solidarity will
    • Solidary News

Miguel Angel García Pérez

Home/INCLIVA analiza el impacto de la arginina en la prevención y tratamiento de la osteoporosis/Miguel Angel García Pérez

Miguel Angel García Pérez

comunicacion2025-10-20T08:12:30+02:0020 de October de 2025|

Comparte en ....

FacebookTwitterLinkedInWhatsAppEmail

WHERE WE ARE

  • FUNDACIÓN INCLIVA
  • Avd. Menendez y Pelayo, 4 acc.
  • 96 197 35 17

TRANSPARENCY PORTAL

  • Transparency portal
  • Complaints Channel

LEGAL NOTICE

  • Legal Notice and Terms of Use
  • Privacy Policy
  • Cookies Policy
  • Cookies Configuration

LANGUAGE

  • Español
  • English
Copyright 2025 | INCLIVA
FacebookTwitterLinkedInInstagramYouTubeCustom
X
Go to Top